then explore this distortion empirically in the context of cancer R&D, where clinical trials are shorter - and hence …, effective patent terms longer - for drugs targeting late-stage cancer patients, relative to drugs targeting early-stage cancer … patients or cancer prevention. Using a newly constructed data set on cancer clinical trial investments, we provide several …